Information Journal Paper
APA:
Copy. (2017). Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immunemediated diseases?. Current Opinion in Toxicology, 2(-), 72-78. SID. https://sid.ir/paper/737228/en
Vancouver:
Copy. Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immunemediated diseases?. Current Opinion in Toxicology[Internet]. 2017;2(-):72-78. Available from: https://sid.ir/paper/737228/en
IEEE:
Copy, “Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immunemediated diseases?,” Current Opinion in Toxicology, vol. 2, no. -, pp. 72–78, 2017, [Online]. Available: https://sid.ir/paper/737228/en